During the past decade, Elixir Research Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elixir Research Group" #1 collaborator was "Cristcot HCA LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Elixir Research Group" are "Alopecia Areata" (1 trials) and "Ulcerative Proctitis" (1 trials). Many other conditions were trialed in "Elixir Research Group" in a lesser frequency.

Most popular intervention types in "Elixir Research Group" are "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CTP-543, 12 mg BID" (1 trials), "CTP-543, 8 mg BID" (1 trials), "Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator" (1 trials), "Placebo, BID" (1 trials) and "Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elixir Research Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Elixir Research Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Elixir Research Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Elixir Research Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".